Literature DB >> 16790804

Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes.

Christine Keller1, Reinhard Hoffmann, Roland Lang, Sven Brandau, Corinna Hermann, Stefan Ehlers.   

Abstract

Classical twin studies and recent linkage analyses of African populations have revealed a potential involvement of host genetic factors in susceptibility or resistance to Mycobacterium tuberculosis infection. In order to identify the candidate genes involved and test their causal implication, we capitalized on the mouse model of tuberculosis, since inbred mouse strains also differ substantially in their susceptibility to infection. Two susceptible and two resistant mouse strains were aerogenically infected with 1,000 CFU of M. tuberculosis, and the regulation of gene expression was examined by Affymetrix GeneChip U74A array with total lung RNA 2 and 4 weeks postinfection. Four weeks after infection, 96 genes, many of which are involved in inflammatory cell recruitment and activation, were regulated in common. One hundred seven genes were differentially regulated in susceptible mouse strains, whereas 43 genes were differentially expressed only in resistant mice. Data mining revealed a bias towards the expression of genes involved in granulocyte pathophysiology in susceptible mice, such as an upregulation of those for the neutrophil chemoattractant LIX (CXCL5), interleukin 17 receptor, phosphoinositide kinase 3 delta, or gamma interferon-inducible protein 10. Following M. tuberculosis challenge in both airways or peritoneum, granulocytes were recruited significantly faster and at higher numbers in susceptible than in resistant mice. When granulocytes were efficiently depleted by either of two regimens at the onset of infection, only susceptible mice survived aerosol challenge with M. tuberculosis significantly longer than control mice. We conclude that initially enhanced recruitment of granulocytes contributes to susceptibility to tuberculosis.

Entities:  

Mesh:

Year:  2006        PMID: 16790804      PMCID: PMC1489748          DOI: 10.1128/IAI.00057-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

1.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

2.  Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.

Authors:  M Uguccioni; M D'Apuzzo; M Loetscher; B Dewald; M Baggiolini
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

3.  T cell-dependent chronic neutrophilia during mycobacterial infections.

Authors:  R Appelberg; M T Silva
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  A role for complement C5 in organism containment and granulomatous response during murine tuberculosis.

Authors:  J K Actor; E Breij; R A Wetsel; H Hoffmann; R L Hunter; C Jagannath
Journal:  Scand J Immunol       Date:  2001-05       Impact factor: 3.487

5.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

6.  Natural inhibitors of neutrophil function in acute respiratory distress syndrome.

Authors:  L Geerts; P G Jorens; J Willems; M De Ley; H Slegers
Journal:  Crit Care Med       Date:  2001-10       Impact factor: 7.598

7.  Susceptibility of beige mice to Mycobacterium avium: role of neutrophils.

Authors:  R Appelberg; A G Castro; S Gomes; J Pedrosa; M T Silva
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections.

Authors:  L E Mombo; C Y Lu; S Ossari; I Bedjabaga; L Sica; R Krishnamoorthy; C Lapoumeroulie
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

9.  Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis.

Authors:  K Kasahara; I Sato; K Ogura; H Takeuchi; K Kobayashi; M Adachi
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Host and bacterial factors control the Mycobacterium avium-induced chronic peritoneal granulocytosis in mice.

Authors:  R Appelberg; J M Pedrosa; M T Silva
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  71 in total

Review 1.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

2.  Colonization with Helicobacter is concomitant with modified gut microbiota and drastic failure of the immune control of Mycobacterium tuberculosis.

Authors:  L Majlessi; F Sayes; J-F Bureau; A Pawlik; V Michel; G Jouvion; M Huerre; M Severgnini; C Consolandi; C Peano; R Brosch; E Touati; C Leclerc
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

3.  B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice.

Authors:  Tatiana K Kondratieva; Elvira I Rubakova; Irina A Linge; Vladimir V Evstifeev; Konstantin B Majorov; Alexander S Apt
Journal:  J Immunol       Date:  2009-12-18       Impact factor: 5.422

Review 4.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

5.  Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts.

Authors:  Alexander V Pichugin; Bo-Shiun Yan; Alex Sloutsky; Lester Kobzik; Igor Kramnik
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

6.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

7.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

8.  The adaptor molecule CARD9 is essential for tuberculosis control.

Authors:  Anca Dorhoi; Christiane Desel; Vladimir Yeremeev; Lydia Pradl; Volker Brinkmann; Hans-Joachim Mollenkopf; Karin Hanke; Olaf Gross; Jürgen Ruland; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

9.  Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium.

Authors:  Elena Kondratieva; Nadya Logunova; Konstantin Majorov; Mikhail Averbakh; Alexander Apt
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

10.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Authors:  Andrea Cruz; Alexandra G Fraga; Jeffrey J Fountain; Javier Rangel-Moreno; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Troy D Randall; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.